Confluent, Inc. Securities Lawsuit Investigation

Shamis & Gentile P.A., a law firm that advocates for investors who are victims of securities fraud, is investigating potential claims against Confluent, Inc. (CFLT).

If you purchased or held Confluent securities and suffered losses, you may be eligible to join this securities investigation and seek compensation.

About Confluent

Confluent, Inc. is a technology company that provides a data streaming platform designed to help organizations harness real-time data. The core offerings are Confluent Cloud and Confluent Platform, which enable businesses to process and analyze data streams at scale.

Concerns Under Investigation

Lawyers are investigating whether Confluent may have made misleading statements or omitted material information that could have impacted investors. The investigation centers on a series of disclosures and events between Feb. 11, 2025, and July 30, 2025, which appear to have significantly affected the company’s stock price and investor confidence.

One key area of focus is the company’s public communications in late 2024 and early 2025. During its Q4 2024 earnings call on Feb. 11, 2025, CEO Jay Kreps stated that Confluent was “in a great position to advance our category lead in 2025,” highlighting a 38% increase in Confluent Cloud revenue. CFO Rohan Sivaram emphasized that Confluent had “become a major data platform...win in the era of cloud, data, and AI,” and pointed to double-digit margin expansion. Management also cited 24% year-over-year revenue growth and claimed “we saw stable consumption and continued use case expansion...driving robust growth”. However, lawyers may investigate whether these statements were overly optimistic and whether Confluent adequately disclosed potential headwinds, such as the risk of a key customer reducing or ending its usage.

Further scrutiny surrounds the Q1 2025 earnings call on April 30, 2025. CEO Jay Kreps described “solid momentum” with 26% subscription growth and continued to emphasize Confluent’s “mission-critical” role in the AI era. CFO Sivaram echoed this optimism, noting “robust first quarter results” and the “resilience of our business” under a diversified strategy. Yet, the company warned of a “modest decline in growth rates, from Q2 through Q4” of 2025, and issued lower-than-expected guidance for Q2 and the full year. Following this announcement, Confluent’s stock dropped about 17% on May 1, 2025.

The most dramatic event occurred after the Q2 2025 earnings release on July 30, 2025. CFO Rohan Sivaram disclosed that “an AI-native customer” was moving to self-managed platforms and significantly reducing its Confluent Cloud usage. He cautioned this would “dampen our Q4 cloud revenue growth” and revealed that the company had only partially offset the loss by selling a Confluent Platform license in Q3. This admission led to a sharp sell-off, with Confluent’s share price falling approximately 33% on July 31, 2025, closing at $17.72, down about $8.68 from the previous day.

Your Rights and Next Steps

Investors who purchased Confluent securities between Feb. 11, 2025, and July 30, 2025, and suffered losses may have important legal rights. This is currently an investigation, not a filed lawsuit. If the investigation uncovers evidence of securities law violations, it could lead to a class action lawsuit seeking to recover damages for affected investors.

Lawyers are ready to help investors understand their options. By joining the investigation, investors can help strengthen the case and potentially improve the chances of a successful recovery. There is no cost to participate in the investigation, and investors are not obligated to take further action unless they choose to do so.

You May Be Entitled to Compensation

If you purchased Confluent securities and experienced financial losses during the period from Feb. 11, 2025, to July 30, 2025, you may be eligible to join this investigation and seek compensation. Lawyers are actively gathering information to determine the scope of potential claims. Completing the form is the first step to protecting your rights and ensuring you are included in any future recovery.

To join the investigation, complete the form below.